- Home
- DNLI vs IOSP Comparison
DNLI vs IOSP Comparison
Compare DNLI & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- IOSP
- Stock Information
- Founded
- DNLI 2013
- IOSP 1938
- Country
- DNLI United States
- IOSP United States
- Employees
- DNLI N/A
- IOSP N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- IOSP Major Chemicals
- Sector
- DNLI Health Care
- IOSP Industrials
- Exchange
- DNLI Nasdaq
- IOSP Nasdaq
- Market Cap
- DNLI 2.1B
- IOSP 2.0B
- IPO Year
- DNLI 2017
- IOSP 1998
- Fundamental
- Price
- DNLI $14.46
- IOSP $83.47
- Analyst Decision
- DNLI Strong Buy
- IOSP Strong Buy
- Analyst Count
- DNLI 15
- IOSP 1
- Target Price
- DNLI $33.85
- IOSP $155.00
- AVG Volume (30 Days)
- DNLI 1.7M
- IOSP 196.9K
- Earning Date
- DNLI 08-11-2025
- IOSP 08-05-2025
- Dividend Yield
- DNLI N/A
- IOSP 1.98%
- EPS Growth
- DNLI N/A
- IOSP N/A
- EPS
- DNLI N/A
- IOSP 0.77
- Revenue
- DNLI N/A
- IOSP $1,790,700,000.00
- Revenue This Year
- DNLI N/A
- IOSP $0.74
- Revenue Next Year
- DNLI $323.34
- IOSP $7.75
- P/E Ratio
- DNLI N/A
- IOSP $110.25
- Revenue Growth
- DNLI N/A
- IOSP N/A
- 52 Week Low
- DNLI $10.57
- IOSP $74.10
- 52 Week High
- DNLI $33.33
- IOSP $128.35
- Technical
- Relative Strength Index (RSI)
- DNLI 53.04
- IOSP 51.59
- Support Level
- DNLI $12.92
- IOSP $74.10
- Resistance Level
- DNLI $15.06
- IOSP $85.30
- Average True Range (ATR)
- DNLI 0.78
- IOSP 2.34
- MACD
- DNLI 0.06
- IOSP 0.49
- Stochastic Oscillator
- DNLI 72.03
- IOSP 83.66
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.